Loading...
Search Filters
Date Range
toReport Types
Condition
Region of the Body
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Showing 1 - 3 of 3
No difference in darexaban taken qd or bid at 30 or 60 mg total in preventing VTE post-THA
Thromb Haemost. 2014 Jan 29;111(2):213-25. doi: 10.1160/TH13-04-0296.
Late PONV reduced with ramosetron vs ondansetron following TKA under spinal anesthesia
J Arthroplasty. 2017 Mar;32(3):1040-1043
Darexaban vs placebo for prevention of VTE in Asian patients receiving TKA or THA
Clin Appl Thromb Hemost. 2014 Mar;20(2):199-211
Showing 1 - 3 of 3